DE3573661D1 - Diagnostic agent for heart disease and use thereof - Google Patents

Diagnostic agent for heart disease and use thereof

Info

Publication number
DE3573661D1
DE3573661D1 DE8585103514T DE3573661T DE3573661D1 DE 3573661 D1 DE3573661 D1 DE 3573661D1 DE 8585103514 T DE8585103514 T DE 8585103514T DE 3573661 T DE3573661 T DE 3573661T DE 3573661 D1 DE3573661 D1 DE 3573661D1
Authority
DE
Germany
Prior art keywords
heart disease
diagnostic agent
diagnostic
agent
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585103514T
Other languages
English (en)
Inventor
Yoshio Yazaki
Masahito Sugi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Application granted granted Critical
Publication of DE3573661D1 publication Critical patent/DE3573661D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8585103514T 1984-03-27 1985-03-25 Diagnostic agent for heart disease and use thereof Expired DE3573661D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59058767A JPS60201260A (ja) 1984-03-27 1984-03-27 心疾患診断薬

Publications (1)

Publication Number Publication Date
DE3573661D1 true DE3573661D1 (en) 1989-11-16

Family

ID=13093693

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585103514T Expired DE3573661D1 (en) 1984-03-27 1985-03-25 Diagnostic agent for heart disease and use thereof

Country Status (7)

Country Link
US (1) US4943427A (de)
EP (1) EP0163041B1 (de)
JP (1) JPS60201260A (de)
KR (1) KR920002166B1 (de)
AU (1) AU566358B2 (de)
CA (1) CA1252714A (de)
DE (1) DE3573661D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877599A (en) * 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
US5726153A (en) * 1988-05-02 1998-03-10 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
US5972890A (en) * 1988-05-02 1999-10-26 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
US5046499A (en) * 1988-06-13 1991-09-10 Centocor, Inc. Method for myocardial infarct risk assessment
CA1340977C (en) * 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US5626830A (en) * 1989-03-23 1997-05-06 Biotech Cardio-Vision, Societe En Commandite Enregistree Anti-myosin mouse monoclonal antibody and method of use for diagnosis of myocardial infarction
CA1311700C (en) * 1989-03-23 1992-12-22 Hanna Sikorska Production and characteristics of anti-myosin mouse monoclonal antibody
DE69019968T2 (de) * 1989-03-28 1995-10-12 Yamasa Shoyu Kk Antikörper gegen die schwere kette eines glatt-muskel-myosins.
JP2829755B2 (ja) * 1989-12-27 1998-12-02 株式会社第一ラジオアイソトープ研究所 抗ヒト心筋ｃプロテインモノクローナル抗体及び該抗体を産生するハイブリドーマ
US5364612A (en) * 1991-05-06 1994-11-15 Immunomedics, Inc. Detection of cardiovascular lesions
US5326778A (en) * 1992-03-03 1994-07-05 Research Corporation Technologies, Inc. Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
CA2202913C (en) * 1994-10-25 2004-07-13 Hirohisa Katoh Antibody reagent for detecting dissecting aortic aneurysm and uses thereof
CA2246666A1 (en) 1996-02-19 1997-08-21 Yamasa Corporation Diagnostic agent for angiopathic diseases
CA2246665A1 (en) * 1996-02-19 1997-08-21 Hirohisa Katoh Diagnostic agent for digestive diseases
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036945A (en) * 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
DE3173342D1 (en) * 1980-03-03 1986-02-13 Milton David Goldenberg Agent for tumor localization and therapy with labeled antibodies and antibody fragments
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same
NO169947C (no) * 1981-10-27 1992-08-26 Hybritech Inc Fremgangsmaate for fremstilling av et monoklonalt antistoff til et tumorassosiert antigen
JPS6028998A (ja) * 1983-07-06 1985-02-14 Yamasa Shoyu Co Ltd 心筋ミオシン重鎖に対する単一クロ−ン抗体

Also Published As

Publication number Publication date
JPS60201260A (ja) 1985-10-11
EP0163041B1 (de) 1989-10-11
KR850006139A (ko) 1985-10-02
US4943427A (en) 1990-07-24
KR920002166B1 (ko) 1992-03-19
AU4037785A (en) 1985-10-03
CA1252714A (en) 1989-04-18
AU566358B2 (en) 1987-10-15
JPH0477733B2 (de) 1992-12-09
EP0163041A1 (de) 1985-12-04

Similar Documents

Publication Publication Date Title
GB8623656D0 (en) Diagnostic catheter
GB2161414B (en) Medical forceps
DE3475269D1 (en) Diagnostic and contrast agent
GB2193620B (en) Computer tomographic phantom
IL78756A0 (en) Catheter and probe
DE3263970D1 (en) Skin care composition
LV10654B (en) Method for preparation of diagnostic composition and the use thereof
JPS57192543A (en) Medical probe
EP0272149A3 (en) Medical dresssings
GB2154731B (en) Non-invasive examination of tooth-jaw structure
DE3573661D1 (en) Diagnostic agent for heart disease and use thereof
DE3464322D1 (en) Patient's support
EP0194886A3 (en) Catheter for intravascular use
GB8413830D0 (en) Blood glucose monitor
DE3566220D1 (en) Patient's support
DE3168233D1 (en) Preparation for the cleaning and care of the human skin
GB2195250B (en) Medical vapourizer
GB8720219D0 (en) Therapeutic agent
GB8705752D0 (en) Diagnostic agents
GB8709781D0 (en) Medical swabs
PL267977A1 (en) Skin care agent
IL75131A (en) Substitute for human blood and its preparation
GB8621181D0 (en) Fish disease diagnosis
AU2564188A (en) Agent for the treatment of heart disease
GB8303186D0 (en) Clinical probe for intracorporeal use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee